Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tracy M Frech

Showing results (91-100 of 104) with videos related to

Pageof 11
Sort By:
Annals of the American Thoracic Society|April 10, 2025
Use of Nintedanib for the Treatment of Systemic Sclerosis-associated Interstitial Lung Disease at Expert Scleroderma Centers in the United StatesYiming Luo, Shervin Assassi, Maureen D Mayes, et al.
The Journal of Rheumatology|January 15, 2025
Psychometric Evaluation of the Scleroderma Skin Questionnaire: A Novel Patient-Reported Outcome for Skin Disease in Patients With Systemic SclerosisJeong Min Yu, John M VanBuren, Angela Child, et al.
Seminars in Arthritis and Rheumatism|January 13, 2015
Antinuclear antibody-negative systemic sclerosisGloria A Salazar, Shervin Assassi, Fredrick Wigley, et al.
The Journal of Rheumatology|November 15, 2025
Type III and type VI collagen neoepitopes are associated with disease severity in systemic sclerosisAli Y Ayla, Elana J Bernstein, Meng Zhang, et al.
The Lancet. Rheumatology|December 30, 2021
Safety and efficacy of abatacept in early diffuse cutaneous systemic sclerosis (ASSET): open-label extension of a phase 2, double-blind randomised trialLorinda Chung, Cathie Spino, Richard McLain, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 19, 2025
Hand swelling and other non-Raynaud's symptoms as the initial presentation of systemic sclerosis: prevalence and clinical associations in two U.S. cohortsIqtidar Hanif, Shervin Assassi, Maureen D Mayes, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 26, 2019
Abatacept in Early Diffuse Cutaneous Systemic Sclerosis: Results of a Phase II Investigator-Initiated, Multicenter, Double-Blind, Randomized, Placebo-Controlled TrialDinesh Khanna, Cathie Spino, Sindhu Johnson, et al.
Arthritis Care & Research|April 20, 2026
Discordance between patient and physician global assessments in early systemic sclerosisEllen Romich, Alexis Ogdie, Alisa Stephens-Shields, et al.
Arthritis Research & Therapy|January 22, 2016
Genetic susceptibility loci of idiopathic interstitial pneumonia do not represent risk for systemic sclerosis: a case control study in Caucasian patientsMinghua Wu, Shervin Assassi, Gloria A Salazar, et al.
Arthritis Care & Research|July 8, 2024
2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic DiseasesSindhu R Johnson, Elana J Bernstein, Marcy B Bolster, et al.
Pageof 11

Showing results (91-100 of 104) with videos related to

Sort By:
Pageof 11
Annals of the American Thoracic Society|April 10, 2025
Use of Nintedanib for the Treatment of Systemic Sclerosis-associated Interstitial Lung Disease at Expert Scleroderma Centers in the United StatesYiming Luo, Shervin Assassi, Maureen D Mayes, et al.
The Journal of Rheumatology|January 15, 2025
Psychometric Evaluation of the Scleroderma Skin Questionnaire: A Novel Patient-Reported Outcome for Skin Disease in Patients With Systemic SclerosisJeong Min Yu, John M VanBuren, Angela Child, et al.
Seminars in Arthritis and Rheumatism|January 13, 2015
Antinuclear antibody-negative systemic sclerosisGloria A Salazar, Shervin Assassi, Fredrick Wigley, et al.
The Journal of Rheumatology|November 15, 2025
Type III and type VI collagen neoepitopes are associated with disease severity in systemic sclerosisAli Y Ayla, Elana J Bernstein, Meng Zhang, et al.
The Lancet. Rheumatology|December 30, 2021
Safety and efficacy of abatacept in early diffuse cutaneous systemic sclerosis (ASSET): open-label extension of a phase 2, double-blind randomised trialLorinda Chung, Cathie Spino, Richard McLain, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 19, 2025
Hand swelling and other non-Raynaud's symptoms as the initial presentation of systemic sclerosis: prevalence and clinical associations in two U.S. cohortsIqtidar Hanif, Shervin Assassi, Maureen D Mayes, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 26, 2019
Abatacept in Early Diffuse Cutaneous Systemic Sclerosis: Results of a Phase II Investigator-Initiated, Multicenter, Double-Blind, Randomized, Placebo-Controlled TrialDinesh Khanna, Cathie Spino, Sindhu Johnson, et al.
Arthritis Care & Research|April 20, 2026
Discordance between patient and physician global assessments in early systemic sclerosisEllen Romich, Alexis Ogdie, Alisa Stephens-Shields, et al.
Arthritis Research & Therapy|January 22, 2016
Genetic susceptibility loci of idiopathic interstitial pneumonia do not represent risk for systemic sclerosis: a case control study in Caucasian patientsMinghua Wu, Shervin Assassi, Gloria A Salazar, et al.
Arthritis Care & Research|July 8, 2024
2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic DiseasesSindhu R Johnson, Elana J Bernstein, Marcy B Bolster, et al.
Pageof 11